Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

Clinical trial NCT04518774 · UNKNOWN

Trial details

NCT number: NCT04518774
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2020-08-15
Primary completion: 2021-06-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.